Ann Partridge, MD, MPH Presents PROs from the COMET Study
Judy Garber, MD, MPH Presents Updated Results of the OlympiA Study
Ada Waks, MD Presents Results of the MARGOT Study
Antonio Giordano, MD, PhD Discusses Novel CDK4-Selective Inhibitor
Jennifer Ligibel, MD Discusses Weigh Loss Intervention
Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates
Panel Discussion: Interesting Cases — Advanced Thyroid Cancer and Parathyroid Disease
Low-Dose Radiation Therapy for Arthritis
Myeloma vs. MUGA: Interpreting the Abnormal SPEP
Cardio-Oncology: Screening & Surveillance
Living-Donor Liver Transplant for Advanced Cancers
Modern Management of Borderline Resectable Pancreatic Cancer
Patients With a History of Breast Cancer who Desire Pregnancy
Cancer Immunotherapy Toxicity Evaluation (CITE) Program
Sacituzumab Govitecan for Metastatic, HR-Positive, HER2-Negative Breast Cancer
Elacestrant for Advanced Estrogen Receptor-Positive Breast Cancer
Cardio-Oncology & Immunology: Specialized Cardiovascular Care for Cancer Patients
Pediatric Precision Cancer Medicine Program
Meet Baptist Health's 'Brains Behind the Brain'
Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo
We All Rise Together: Dr. Camille Ragin's Vision for Health Equity in Cancer Care
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers
First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-Farber
Dana-Farber Researchers ‘Hijack’ Gut Bacteria to Design Novel Form of Cancer Immunotherapy
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
